February 26, 2024
In a post-pandemic world, the pharmaceutical sector is undergoing a paradigm shift by embracing ESG principles at its core. Beyond its historical focus on life-saving medications, the industry is increasingly aligning with broader sustainability goals.
This white paper aims to shed light on how ESG considerations intersect with and influence the Indian pharmaceutical industry towards a positive change. The pharmaceutical industry's adoption of ESG principles not only addresses critical global challenges but also enhances operational efficiency, attracts investors, and elevates brand reputation in an ESG-focused business landscape. As the sector navigates these changes, it is poised to become a transformative force for sustainable growth.
Download a PDF here